Journal of Clinical Medicine (Mar 2022)

Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism

  • Samuel Frey,
  • Raphaël Bourgade,
  • Cédric Le May,
  • Mikaël Croyal,
  • Edith Bigot-Corbel,
  • Nelly Renaud-Moreau,
  • Matthieu Wargny,
  • Cécile Caillard,
  • Eric Mirallié,
  • Bertrand Cariou,
  • Claire Blanchard

DOI
https://doi.org/10.3390/jcm11051373
Journal volume & issue
Vol. 11, no. 5
p. 1373

Abstract

Read online

Background: The benefits of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism (PHPT) are controversial. This monocentric, observational, prospective study aimed to assess the effects of parathyroidectomy on glucose and lipid metabolism in classic or mild PHPT. Methods: Patients who underwent parathyroidectomy for classic (calcemia >2.85 mmol/L) or mild PHPT (calcemia ≤2.85 mmol/L) between 2016 and 2019 were included. A metabolic assessment was performed before and 1 year after parathyroidectomy. Patients with a history of diabetes were excluded. Results: Nineteen patients had classic and 120 had mild PHPT. Ninety-five percent were normocalcemic 6 months after surgery. Fasting plasma glucose and insulin levels decreased after parathyroidectomy in patients with mild PHPT (p p p = 0.005) and mild PHPT (p p = 0.021). Plasma PCSK9 levels decreased in patients with mild PHPT (p < 0.001). Conclusions: Parathyroidectomy for PHPT improves insulin resistance and decreases plasma triglyceride levels in classic PHPT and plasma PCSK9 levels in mild PHPT. Further studies are needed to better characterize the consequences of such metabolic risk factors’ improvements on cardiovascular events.

Keywords